According to a new report published by Allied Market Research, the global plasma therapy market was valued at $350.21 million in 2020 and is projected to reach $698.46 million by 2030, registering a CAGR of 8.5% from 2021 to 2030.
Plasma therapy, a widely used regenerative treatment, utilizes blood plasma enriched with platelets and growth factors to accelerate healing processes. It has gained significant traction across multiple medical specialties, including orthopedics, dermatology, and dentistry, due to its effectiveness in tissue repair, wound healing, and aesthetic treatments.
Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/14049
Market Drivers, Restraints, and Opportunities
The growth of the plasma therapy market is primarily driven by the increasing prevalence of life-threatening and chronic diseases, such as neurological disorders including chronic inflammatory demyelinating polyneuropathy (CIDP), idiopathic thrombocytopenic purpura (ITP), and multifocal motor neuropathy (MMN).
In addition, the rising incidence of infectious diseases such as hepatitis, tetanus, and rabies, along with a growing geriatric population more susceptible to such conditions, is expected to boost demand for plasma-based therapies.
However, the high cost associated with plasma therapy procedures remains a key factor restraining market growth. Despite this, increasing adoption in treating orthopedic disorders, androgenic alopecia, and sports injuries is expected to create lucrative opportunities in the coming years.
Impact of COVID-19
The COVID-19 pandemic had a notable positive impact on the plasma therapy market. Convalescent plasma therapy emerged as a potential treatment for hospitalized COVID-19 patients, with regulatory authorities such as the U.S. FDA granting emergency use authorization.
The use of plasma derived from recovered patients helped accelerate research and adoption of plasma-based therapies, further driving market expansion during the pandemic period.
Segment Highlights
By type, the pure platelet-rich plasma (PRP) segment held the largest market share in 2020, owing to its high efficacy and increasing use in clinical settings.
Based on application, the orthopedics segment dominated the market, driven by a rise in musculoskeletal disorders such as arthritis and increasing healthcare expenditure.
In terms of end users, hospitals accounted for the largest share due to higher patient inflow and availability of advanced treatment infrastructure.
Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/14049
Regional Insights
North America dominated the global plasma therapy market and is expected to maintain its lead during the forecast period, attributed to strong R&D activities and advanced healthcare infrastructure.
Meanwhile, the Asia-Pacific region is anticipated to witness significant growth, driven by increasing population, rising awareness about blood donation, and expanding healthcare facilities.
Key Players
Key companies operating in the plasma therapy market include MTF Biologics, Regen Lab SA, Arthrex, Terumo Corporation, Zimmer Biomet, Johnson & Johnson (DePuy Synthes), Exactech, Inc., Pfizer Inc., and Teva Pharmaceutical Industries Ltd.
Conclusion
The global plasma therapy market is poised for steady growth, supported by advancements in regenerative medicine, increasing disease burden, and expanding clinical applications. As healthcare systems continue to evolve, plasma therapy is expected to play a crucial role in modern treatment approaches, offering improved healing outcomes and patient care.
Other Trending Reports in Life Science Domain
How Big Is the Pharmaceutical Primary Packaging Label Market by 2032? Size, Share & CAGR Analysis
Hepatitis Therapeutics Market Size: $19.17 Billion by 2030 | 3.1% CAGR Growth
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
